Tectonic therapeutic to host kol event on the unmet need in group 2 ph-hfpef and tx45 as a potential treatment on thursday, december 12, 2024

Watertown, mass., dec. 03, 2024 (globe newswire) -- tectonic therapeutic, inc. (nasdaq: tecx) (“tectonic”) a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of g-protein coupled receptors (“gpcrs”), today announced it will host a virtual key opinion leader (kol) event on thursday, december 12, 2024 from 4:00 pm to 6:00 pm et. to register, click here .
TECX Ratings Summary
TECX Quant Ranking